Selventa

Selventa Raises $5M

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Life science data analysis firm Selventa has raised $5 million in an equity round, it disclosed in a document filed with the US Securities and Exchange Commission this week.

Selventa said this week that it has partnered with Linguamatics to add natural language processing-based text-mining capability to its knowledge-extraction and discovery platform.

People in the News

Premium

Selventa CEO David de Graaf has been selected to serve on the scientific advisory board of the Massachusetts Institute of Technology's Center for Cancer Systems Biology.

People in the News

Premium

The Swiss Institute of Bioinformatics has tapped Selventa's CEO David de Graaf and Alexey Nesvizhskii, an assistant professor at the University of Michigan, Ann Arbor, to serve on its scientific advisory board.

Movers & Shakers

Premium

The Swiss Institute of Bioinformatics has appointed David de Graaf and Alexey Nesvizhskii to serve on its scientific advisory board.

People in the News

Premium

Luis Serrano, James Collins, Mathukumalli Vidyasagar, Joel Saltz

Pfizer and Selventa plan to create a publicly available version of Selventa's Biological Expression Language and associated BEL Framework that will enable groups to capture, store, combine, and use scientific knowledge to inform decision-making for drug targets.

People in the News

Premium

John Tagliamonte

Pages

Thermo Fisher Scientific says it will no longer sell machines in China's Xinjiang region, according to the Wall Street Journal.

The University of Zurich's Ruedi Aebersold and his colleagues analyzed a dozen HeLa cell lines to find differences in gene expression, protein levels, and more.

New Scientist reports that 20 percent of human and yeast proteins are uncharacterized.

In Nature this week: protein-coding variants associated with body-fat distribution, and more.